although mitomycin dosages were successfully titrated according to platelet counts in this group of chemotherapy-refractory patients , prolonged use of this drug in adjuvant or early metastatic breast cancer patients is not recommended because of potentially irreversible thrombocytopenia .
C0002475
mitomycin
C0040034
thrombocytopenia